semaglutide inner thigh How to inject for weight loss How to inject GLP-1 in

73 (2):354-363.e3 71

Food and Drug Administration (FDA) expanded Wegovys approved uses to include reducing the risk of cardiovascular death, heart attack, and stroke in adults who are obese, overweight, or have established cardiovascular disease

One potential risk is the incidence of acute pancreatitis, which was observed at a rate of 0.3% in the placebo group during trials

The result is fewer sharp post-meal glucose and insulin spikes

If left unaddressed, it can become uncomfortable and impact adherence to therapy

Thinking, memory and other cognitive problems are noticeable to those affected, friends and family members, but do not interfere with individuals ability to carry out everyday activities